-- Hansoh Pharmaceutical's (HKG:3692) HS-20093 for injection in combination with adebrelimab obtained approval to be included as a Breakthrough Therapy Designated Drug from China's National Medical Products Administration, according to a Thursday Hong Kong bourse filing.
The approval is for the indication of locally advanced or metastatic non-small cell lung cancer.
Charles Schwab (SCHW) said Thursday it will launch a spot cryptocurrency trading service for retail customers in the coming weeks.The platform will initially provide direct trading of bitcoin and ethereum alongside traditional investments for a fee of 75 basis points per transaction, the company said.Clients will hold a separate digital asset account through Charles Schwab Premier Bank, while Paxos will manage trade execution and sub-custody services, it added.Price: $94.86, Change: $-5.41, Percent Change: -5.40%
Morgan Stanley (MS) is likely to reward shareholders through stock buybacks and dividend hikes, given its excess capital position following robust Q1 results, RBC Capital Markets said in a Wednesday research report.The company's investment services business model with multiple growth engines delivered "outstanding" results in Q1, driven by its premier investment banking and trading businesses, the RBC analysts said.Return on tangible common equity in Q1 expanded to 27.1% from a year earlier, which is a validation of the strategy of connecting institutional securities, wealth management, and investment management into a "unified flywheel" of earnings power, according to the note.The brokerage now expects 2026 and 2027 EPS of $12.10 and $12.80, respectively, from $12 and $12.60 earlier.RBC reiterated its sector perform rating on the stock and the price target of $207 per share.Price: $188.62, Change: $-3.00, Percent Change: -1.57%
Arya Resources (RBZ.V) on Thursday said it increased the flow-through component of the previously announced non-brokered private placement to $2.19 million, from $2 million.The company said the upsized flow-through component will now consist of up to near 4.4-million flow-through common shares (FT shares) at $0.50 per FT share."We initially capped the flow-through financing at $2.0 million, with only a modest increase to $2.19 million to manage dilution prudently," said Arya Resources Chief Executive Rasool Mohammad. "While demand was strong, we elected not to accept additional subscriptions to maintain a disciplined capital structure and minimize dilution to our shareholders."The proceeds from the FT shares will be used to incur eligible "Canadian exploration expenses" that qualify as "flow-through mining expenditures" and will be renounced to subscribers with an effective date no later than Dec. 31, 2026. Funds will be directed toward the continued advancement of its Saskatchewan exploration projects, including the Wedge Lake Gold project and the Dunlop Nickel-Copper-Cobalt project.Shares of the company were last seen unchanged at $0.45 on the TSX Venture Exchange.